(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-guanidino-pentanoyl]amino]-3-phenyl-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-3-phenyl-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]butanedioic acid

ID: ALA4243009

Chembl Id: CHEMBL4243009

PubChem CID: 145985495

Max Phase: Preclinical

Molecular Formula: C69H91N15O15

Molecular Weight: 1370.58

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O

Standard InChI:  InChI=1S/C69H91N15O15/c1-5-40(4)58(83-59(89)48(70)35-45-37-73-38-75-45)67(97)84-29-13-19-56(84)66(96)76-49(18-12-28-74-69(71)72)60(90)78-51(31-41-14-8-6-9-15-41)63(93)80-53(33-43-20-24-46(85)25-21-43)62(92)77-50(30-39(2)3)61(91)79-52(32-42-16-10-7-11-17-42)64(94)81-54(34-44-22-26-47(86)27-23-44)65(95)82-55(68(98)99)36-57(87)88/h6-11,14-17,20-27,37-40,48-56,58,85-86H,5,12-13,18-19,28-36,70H2,1-4H3,(H,73,75)(H,76,96)(H,77,92)(H,78,90)(H,79,91)(H,80,93)(H,81,94)(H,82,95)(H,83,89)(H,87,88)(H,98,99)(H4,71,72,74)/t40-,48-,49-,50-,51-,52-,53-,54-,55-,56-,58-/m0/s1

Standard InChI Key:  PXSRBAFJNWPMBY-JUVBYKDMSA-N

Alternative Forms

  1. Parent:

    ALA4243009

    ---

Associated Targets(Human)

TLR2 Tchem Toll-like receptor 1/2 (401 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR2 Tchem TLR2/TLR6 (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tlr2 Toll-like receptor 1/2 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tlr4 Toll-like receptor 4 (808 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tlr7 TLR7 and TLR8 (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tlr3 Toll-like receptor 3 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1370.58Molecular Weight (Monoisotopic): 1369.6819AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Ebner S, Trieb M, Schönfeld M, Wietzorrek G, Santos-Sierra S..  (2018)  Decoy peptides derived from the extracellular domain of toll-like receptor 2 (TLR2) show anti-inflammatory properties.,  26  (16): [PMID:30093346] [10.1016/j.bmc.2018.07.013]

Source